bioRxivMolecular BiologyPreprint
Structural basis of saccharine derivative inhibition of carbonic anhydrase IX
Jānis LeitānsiD, Andris KazāksiD, Jānis BogansiD, Claudiu Trandafir SupuraniD, Ināra Akopjana, Jekaterīna IvanovaiD, Raivis ŽalubovskisiD, Kaspars TārsiD
Abstract
This scientific study explores the binding mechanisms of saccharine derivatives with human carbonic anhydrase IX (hCA IX), an antitumor drug target, with the aim of facilitating the design of potent and selective inhibitors. Through the use of crystallographic analysis, we investigate the structures of hCA IX - saccharine derivative complexes, unveiling their unique binding modes that exhibit both similarities to sulfonamides and distinct orientations of the ligand tail. Our comprehensive structural insights provide information regarding the crucial interactions between the ligands and the protein, shedding light on interactions that dictate inhibitor binding and selectivity. Through a comparative analysis of the binding modes observed in hCA II and hCA IX, isoform-specific interactions are identified, offering promising strategies for the development of isoform-selective inhibitors that specifically target tumor-associated hCA IX. The findings of this study significantly deepen our understanding of the binding mechanisms of hCA inhibitors, laying a solid foundation for the rational design of more effective inhibitors.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeted anticancer pre-vinylsulfone covalent inhibitors of carbonic anhydrase IX
Aivaras Vaškevičius, Denis Baronas, … Daumantas Matulis·eLifePeer-reviewed·Sep 26, 2024
- Selective inhibition of CA IX over CA XII using benzene sulfonamides in breast cancer cells: Disconnect between CA activity and growth inhibition
M. Y. Mboge, Z. Chen, … S. C. Frost·bioRxiv·Sep 18, 2018
- Computationally Designed Carbonic Anhydrase Inhibitors Derived from Sulfonamides for Treatment of Glaucoma
D. J. Caruso, M. P. Connolly, … J. B. Siegel·bioRxiv·Feb 25, 2023
- Structural basis of insulin receptor antagonism by bivalent site 1-site 2 ligands
Amber Vogel, Alan Blakely, … Christopher P. Hill·bioRxiv·Aug 23, 2025
- Structural insights into dual-antagonize mechanism of AB928 on adenosine A2 receptors
- Discovery of Covalent Wild-Type Isocitrate Dehydrogenase 1 (IDH1) Inhibitors Targeting Cys269
C. C. Brown, Elliot O Harmer, … David J. Mann·bioRxiv·Sep 25, 2026